Vini Doraiswamy Email

Chief Scientific Officer . AtriCure

Current Roles

Employees:
1247
Revenue:
$500.8M
About
AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 33 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure's Isolator® Synergy Ablation System is the first and only medical device to receive FDA approval for the treatment of persistent Afib. AtriCure's AtriClip Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide, with more than 150,000 implanted to date. For more information, visit AtriCure.com or follow us on Twitter @AtriCure.
AtriCure Address
7555 Innovation Way
Mason, OH
United States
AtriCure Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.